Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treximet and Inflammatory Markers in Migraine
NCT01138150Phase 4Completed
- Sponsor
- Johns Hopkins University
- Start
- Sep 2009
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sumatriptan in migraine, sponsored by Johns Hopkins University. Started Sep 2009; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT01138150.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01138150.